Navellier & Associates Inc Pfizer Inc Transaction History

Navellier & Associates Inc

  • $792 Million
  • Q4 2024

A detailed history of Navellier & Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Navellier & Associates Inc holds 7,840 shares of PFE stock, worth $201,801. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,840
Previous 14,618 46.37%
Holding current value
$201,801
Previous $423,000 51.06%
% of portfolio
0.03%
Previous 0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025
SELL
$24.8 - $30.19 $168,094 - $204,627
-6,778 Reduced 46.37%
7,840 $207,000
Q4 2023

Feb 08, 2024
SELL
$26.13 - $33.94 $153,435 - $199,295
-5,872 Reduced 28.66%
14,618 $420,000
Q3 2023

Nov 09, 2023
BUY
$32.09 - $37.51 $657,524 - $768,579
20,490 New
20,490 $679,000
Q1 2021

May 12, 2021
SELL
$33.49 - $37.77 $1.98 Million - $2.23 Million
-59,162 Closed
0 $0
Q4 2020

Feb 05, 2021
SELL
$33.47 - $42.56 $113,530 - $144,363
-3,392 Reduced 5.42%
59,162 $2.18 Million
Q3 2020

Nov 09, 2020
SELL
$31.75 - $37.25 $164,719 - $193,253
-5,188 Reduced 7.66%
62,554 $2.3 Million
Q2 2020

Aug 12, 2020
SELL
$30.12 - $36.54 $120,449 - $146,123
-3,999 Reduced 5.57%
67,742 $2.22 Million
Q1 2020

May 13, 2020
SELL
$27.03 - $38.62 $165,964 - $237,126
-6,140 Reduced 7.88%
71,741 $2.34 Million
Q4 2019

Feb 12, 2020
BUY
$32.92 - $37.36 $48,161 - $54,657
1,463 Added 1.91%
77,881 $3.05 Million
Q3 2019

Oct 16, 2019
BUY
$32.49 - $42.13 $174,406 - $226,153
5,368 Added 7.56%
76,418 $2.75 Million
Q2 2019

Jul 17, 2019
BUY
$36.98 - $41.52 $70,816 - $79,510
1,915 Added 2.77%
71,050 $3.08 Million
Q1 2019

May 15, 2019
SELL
$37.5 - $41.2 $8,812 - $9,682
-235 Reduced 0.34%
69,135 $2.94 Million
Q4 2018

Jan 15, 2019
BUY
$38.47 - $43.86 $18,734 - $21,359
487 Added 0.71%
69,370 $3.03 Million
Q3 2018

Nov 14, 2018
SELL
$34.47 - $41.81 $7,307 - $8,863
-212 Reduced 0.31%
68,883 $3.04 Million
Q2 2018

Aug 06, 2018
BUY
$32.98 - $35.16 $34,266 - $36,531
1,039 Added 1.53%
69,095 $2.51 Million
Q1 2018

May 21, 2018
BUY
$31.91 - $37.02 $1.84 Million - $2.14 Million
57,785 Added 562.6%
68,056 $2.42 Million
Q4 2017

Feb 12, 2018
BUY
$33.26 - $35.29 $14,102 - $14,962
424 Added 4.31%
10,271 $372,000
Q3 2017

Nov 14, 2017
SELL
$31.0 - $34.15 $12,183 - $13,420
-393 Reduced 3.84%
9,847 $352,000
Q2 2017

Aug 24, 2017
BUY
N/A
10,240
10,240 $344,000

Others Institutions Holding PFE

# of Institutions
3,244
Shares Held
3.65B
Call Options Held
77.2M
Put Options Held
122M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Navellier & Associates Inc Portfolio

Follow Navellier & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Navellier & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email